Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Read the MDA for Q1 2020

<< Previous

Bullboard Posts

Next >>

Comment by GunnerGon Jun 12, 2020 11:31pm

80 Views

Post# 31146031

RE:RE:RE:RE:RE:RE:RE:Read the MDA for Q1 2020

This posted one month ago and still nothing. You guys just keep making up BS.

GunnerG wrote: "This suggests That BLA submission is ready". I could not find in the MDA this quote. Please explain why they don't submit the paperwork then if its ready? Nine months since processes completed.

Sah you have been wrong so many times; under the old management and new management.

"and approved in due course" , exactly the suggestions you were making years ago.

Company around for ~25 years, COVID for five months, lets blame COVID. LOL

sah1 wrote: Ualcin, I am just repeating words that I read in the MDA. Covid is a curse on humanity but also small busiesses including Lmnl. Galbraith said that the company had run the new quality control system successfully for 6 months. This suggests That Bla submission is ready and would be successful and approved in due course. But this can’t happen in the near term nor can the marketing deal . Looks like times are going to be very tough.